Watch BDTB. Know when insiders buy.
One email the day a filing lands. Free.
BDTB
Bodhi Tree Biotechnology Inc
0.28
+0.00 +0.00%
USD · close Oct 22
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
—
not graded: no insider, short or call data yet
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $7.2MP/E —DIV YIELD —FCF YIELD —REV TTM $37KNET INCOME −$116KNET CASH —52W 0.15 – 0.28SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q3 2026 · Jun 30 | $10K | — | — | −$23K | −$23K | — | 0.00 | −$19K | — | — | Aug 14 |
| Q2 2026 · Mar 31 | $15K | — | — | −$28K | −$29K | — | 0.00 | −$25K | — | — | May 14 |
| Q1 2026 · Dec 31 | $0 | −100.0% | — | −$53K | −$53K | — | -0.01 | −$62K | — | — | Feb 13 |
| Q4 2025 · Sep 30derived | $12K | −20.0% | — | −$11K | −$11K | −209.9% | -0.01 | −$10K | — | — | Dec 29 |
| Q3 2025 · Jun 30 | $0 | — | — | −$20K | −$21K | — | 0.00 | −$25K | — | — | Aug 14 |
| Q2 2025 · Mar 31 | $0 | — | — | −$52K | −$53K | — | 0.00 | −$50K | — | — | May 14 |
| Q1 2025 · Dec 31 | $5K | — | — | −$65K | −$65K | — | 0.00 | −$65K | — | — | Feb 13 |
| Q3 2024 · Jun 30 | $15K | — | — | $10K | $10K | — | 0.00 | — | — | — | Aug 12 |
| Q2 2024 · Mar 31 | — | — | — | −$116 | −$116 | — | — | — | — | — | May 20 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Sep 30 | $17K | — | −$148K | −$150K | -880.4% | -0.01 | −$150K | — | — | — | — |
Every number comes from Bodhi Tree Biotechnology Inc's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.